Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2024) 99 EP1206 | DOI: 10.1530/endoabs.99.EP1206

1Habib Bourguiba University Hospital, Department of Nuclear Medicine; 2Hedi Chaker University Hospital, Department of Endocrinology


Introduction: Papillary thyroid carcinoma (PTC) is the most common histological form of thyroid neoplasm, increasingly diagnosed at the microcarcinoma stage (tumor diameter ≤10 mm). The majority of papillary thyroid microcarcinomas (PTMC) are not recognizable during physical exam and are commonly diagnosed fortuitously during histopathologic analysis of thyroid specimens following surgery for benign thyroid conditions. The aim of our study was to identify different clinical and pathological characteristics of PTMC.

Patients and Methods: A retrospective study including 51 patients who were followed for PTMC, at the department of nuclear medicine at Habib Bourguiba hospital, Sfax-Tunisia. Clinical, pathological and therapeutic characteristics were analyzed.

Results: The average age of patients was 44.6 ± 8,9 years. There were 46females and only 3 males PTMC was diagnosed after thyroid nodule and nodular goiter surgery in 41.25% and 23,5 % of cases, respectively. Cervical lympadenopathy was found in 25.5% of cases. Only one patient had a lymph node metastasis. All patients underwent total thyroidectomy and cervical lymphadenectomy was performed in 80 % of patients. Pathological examination revealed a vesicular variant in 23.5% of patients and a classic variant of PTC in 76.5% of patients. Multifodality was found in 68% of patients. The mean tumor diameter was of 3.9 mm (1 mm-10 mm). Lymph node involvement was confirmed in 20 % of patients. Lymphocytic thyroiditis was observed in 35.4% of patients. Capsular rupture was found in 43.1% of surgical specimens.

Conclusions: PTMC present various clinical and histopathological features that emplace them on the borderline of benignity. However, regular follow-up is of a great importance in the management of the tumors, as late recurrence may occur.

Volume 99

26th European Congress of Endocrinology

Stockholm, Sweden
11 May 2024 - 14 May 2024

European Society of Endocrinology 

Browse other volumes

Article tools

My recent searches

No recent searches.